BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/14/2022 7:20:14 AM | Browse: 171 | Download: 357
 |
Received |
|
2022-10-11 02:15 |
|
Peer-Review Started |
|
2022-10-11 02:17 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-11-02 03:15 |
|
Revised |
|
2022-11-10 02:22 |
|
Second Decision |
|
2022-11-24 03:06 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-11-24 06:45 |
|
Articles in Press |
|
2022-11-24 06:45 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-11-30 15:55 |
|
Publish the Manuscript Online |
|
2022-12-14 07:20 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Case Report |
| Article Title |
Response to roxadustat in a patient undergoing long-term dialysis and allergic to erythropoiesis-stimulating agents: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Cai Xu, Deng-Gui Luo, Zhe-Yan Liu, Dong Yang, Dan-Dan Wang, Yuan-Zhao Xu, Jun Yang, Bo Fu and Ai-Rong Qi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ai-Rong Qi, PhD, Chief Physician, Department of Nephrology, The Fourth Affiliated Hospital of Guangzhou University of Chinese Medicine, No. 1 Fuhua Road, Futian District, Shenzhen, Shenzhen 518000, Guangdong Province, China. 81863418@163.com |
| Key Words |
Chronic kidney disease; Hemodialysis; Anemia; Roxadustat; Erythropoiesis- stimulating agents; Allergic shock; Case report |
| Core Tip |
Anemia of dialysis-dependent chronic kidney disease is commonly treated with erythropoiesis-stimulating agents (ESAs), along with iron supplementation; however, in some cases, patients cannot be administered erythropoiesis-stimulating agents. Roxadustat is a newly developed drug for renal anemia treatment. It is an oral hypoxia-inducible factor-prolyl hydroxylase inhibitor (HIF-PHI) that stimulates erythropoiesis and regulates iron metabolism. In this study, we presented a case in which Roxadustat was administered for the treatment of a patient allergic to ESAs. This was the first case where roxadustat was administered to improve anemia in a patient allergic to ESAs and on maintenance hemodialysis. |
| Publish Date |
2022-12-14 07:20 |
| Citation |
Xu C, Luo DG, Liu ZY, Yang D, Wang DD, Xu YZ, Yang J, Fu B, Qi AR. Response to roxadustat in a patient undergoing long-term dialysis and allergic to erythropoiesis-stimulating agents: A case report. World J Clin Cases 2022; 10(35): 13122-13128 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i35/13122.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i35.13122 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
